Food And Drug Administration Predictions & Odds· 150 markets

F
FDA approves Retatrutide this year?

FDA approves Retatrutide this year?

18%

Yes

$561k Vol.
$4k Liq.
3
Ends in 9 months
F
FDA approves a psychedelic for medical use in 2026?

20%

Yes

$383 Vol.
$8k Liq.
Ends in 9 months
F
FDA approves Grace Therapeutics’ GTx-104?

77%

Yes

$64 Vol.
$1k Liq.
Ends in 5 days
F
FDA approves Dordaviprone?

FDA approves Dordaviprone?

Yes

$14k Vol.
$0 Liq.
12
Ended
F
FDA approves UX111?

FDA approves UX111?

No

$41k Vol.
$0 Liq.
12
Ended
F
FDA approves EYLEA HD?

FDA approves EYLEA HD?

No

$6k Vol.
$0 Liq.
12
Ended
F
FDA approves Donidalorsen?

Yes

$4k Vol.
$0 Liq.
12
Ended
F
FDA approves FILSPARI REMS modification?

Yes

$1k Vol.
$0 Liq.
12
Ended
F
FDA approves Leqembi auto-injection for early Alzheimer’s?

Yes

$2k Vol.
$0 Liq.
12
Ended
F
FDA approves Outlook Therapeutics’ ONS-5010 for wet AMD?

No

$4k Vol.
$0 Liq.
4
Ended
F
FDA approves Tonix Pharmaceuticals’ TNX-102 SL for fibromyalgia?

Yes

$916 Vol.
$0 Liq.
12
Ended
F
FDA approves Insmed’s Brensocatib for bronchiectasis?

Yes

$2k Vol.
$0 Liq.
12
Ended
F
FDA approves PharmaTher Holdings’ Ketamine?

Yes

$7k Vol.
$0 Liq.
12
Ended
F
FDA approvals in July

FDA approvals in July

TransCon hGH (sBLA)

$108k Vol.
$0 Liq.
12
Ended